Spero Biopharma For Profit
Spero Biopharma is developing Ladostigil an innovative treatment for Mild Cognitive Impairment. Spero Biopharma was founded by Prof. Marta Weinstock-Rosin, a world-renowned researcher of Alzheimer's disease. Prof. Weinstock-Rosin is the inventor of Exelon¬Ѓ, a blockbuster drug for the treatment of AlzheimerвАЩs disease, and a professor emeritus at the Hebrew UniversityвАЩs School of Pharmacy-Institute for Drug Research in the Faculty of Medicine.
Founded Date:
2019
Headquarters:
Tel Aviv
Technology:
Meditations &mindfulness
Industry:
Mental Health